401k Record

Employers › Envision Pharma

Envision Pharma 401(k)

Recordkeeping fees per participant · Envision Pharma, Inc. 401(k) Plan · plan year 2024

$125.72

Higher than 84% of the 5,847 plans $50 to 250M that report it.

Source

= $110,759 / 881
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251015052638NAL0008291282001, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015052638NAL0008291282001, received 2025-10-15

10th: $10.22median $69.9190th: $151.08

Percentiles compare this plan with the Schedule H plans $50 to 250M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-10-15.

Cost and contributions

Administrative expenses excluding investment management, per participant

$125.72

10th: $16.21median $93.2090th: $246.84

Higher than 66% of the 8,758 plans $50 to 250M that report it.

Source

= $110,759 / 881
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251015052638NAL0008291282001, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015052638NAL0008291282001, received 2025-10-15

Administrative expenses per participant

$323.73

10th: $29.39median $132.8490th: $350.58

Higher than 88% of the 9,042 plans $50 to 250M that report it.

Source

= $285,205 / 881
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251015052638NAL0008291282001, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015052638NAL0008291282001, received 2025-10-15

Administrative expenses as a share of assets

0.310%

10th: 0.022%median 0.136%90th: 0.326%

Higher than 88% of the 9,049 plans $50 to 250M that report it.

Source

= $285,205 / $92,054,197
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251015052638NAL0008291282001, received 2025-10-15
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251015052638NAL0008291282001, received 2025-10-15

Employer contributions per participant

$3,825

10th: $965median $2,73890th: $8,164

Higher than 67% of the 9,105 plans $50 to 250M that report it.

Source

= $3,369,899 / 881
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251015052638NAL0008291282001, received 2025-10-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015052638NAL0008291282001, received 2025-10-15

Employer share of total contributions

25.1%

10th: 15.6%median 29.5%90th: 50.6%

Higher than 35% of the 9,112 plans $50 to 250M that report it.

Source

= $3,369,899 / $13,435,368
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251015052638NAL0008291282001, received 2025-10-15
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251015052638NAL0008291282001, received 2025-10-15

Plan terms, as stated in Envision Pharma, Inc.'s SEC filings

Plan terms are not published in public filings.

Plan features

2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2R participant brokerage window · 2T default investment (QDIA) · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20251015052638NAL0008291282001, received 2025-10-15

Full record, Envision Pharma, Inc. 401(k) Plan

FieldValueSource
Plan sponsorENVISION PHARMA, INC.Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20251015052638NAL0008291282001, received 2025-10-15
Plan nameENVISION PHARMA, INC. 401(K) PLANForm 5500, line 1a; PLAN_NAME pos 16; filing 20251015052638NAL0008291282001, received 2025-10-15
Sponsor EIN / plan number06-1633253 / 001Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20251015052638NAL0008291282001, received 2025-10-15
Plan typesingle-employerForm 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20251015052638NAL0008291282001, received 2025-10-15
Sponsor locationFAIRFIELD, CTForm 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20251015052638NAL0008291282001, received 2025-10-15
Industry (business code)541990, Professional, scientific, and technical servicesForm 5500, line 2d; BUSINESS_CODE pos 46; filing 20251015052638NAL0008291282001, received 2025-10-15
Plan year2024-01-01 to 2024-12-31Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20251015052638NAL0008291282001, received 2025-10-15
Filing received2025-10-15Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20251015052638NAL0008291282001, received 2025-10-15
Final filingnoForm 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20251015052638NAL0008291282001, received 2025-10-15
Amended filingnoForm 5500, Part I line B; AMENDED_IND pos 7; filing 20251015052638NAL0008291282001, received 2025-10-15
Participants, beginning of year998Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20251015052638NAL0008291282001, received 2025-10-15
Active participants758Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20251015052638NAL0008291282001, received 2025-10-15
Participants, end of year959Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20251015052638NAL0008291282001, received 2025-10-15
Participants with an account balance881Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251015052638NAL0008291282001, received 2025-10-15
Total assets, beginning of year$77,496,149Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20251015052638NAL0008291282001, received 2025-10-15
Total assets, end of year$92,054,197Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251015052638NAL0008291282001, received 2025-10-15
Net assets, end of year$92,014,076Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20251015052638NAL0008291282001, received 2025-10-15
Total income$25,034,081Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20251015052638NAL0008291282001, received 2025-10-15
Net income$14,551,137Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20251015052638NAL0008291282001, received 2025-10-15
Employer contributions$3,369,899Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251015052638NAL0008291282001, received 2025-10-15
Participant contributions$8,541,000Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20251015052638NAL0008291282001, received 2025-10-15
Other contributions (incl. rollovers)$1,524,469Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20251015052638NAL0008291282001, received 2025-10-15
Total contributions$13,435,368Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251015052638NAL0008291282001, received 2025-10-15
Benefit payments$10,159,866Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20251015052638NAL0008291282001, received 2025-10-15
Total expenses (incl. benefit payments)$10,482,944Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20251015052638NAL0008291282001, received 2025-10-15
Total administrative expenses$285,205Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251015052638NAL0008291282001, received 2025-10-15
Recordkeeping fees$110,759Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251015052638NAL0008291282001, received 2025-10-15
Investment advisory and management fees$174,446Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20251015052638NAL0008291282001, received 2025-10-15
Administrative expenses excluding investment management$110,759derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251015052638NAL0008291282001, received 2025-10-15
Held in common/collective trusts$3,498,192Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20251015052638NAL0008291282001, received 2025-10-15
Held in mutual funds$88,080,542Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20251015052638NAL0008291282001, received 2025-10-15
Independent auditorASSURANCE DIMENSIONS, LLCSchedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20251015052638NAL0008291282001, received 2025-10-15

Position = column in the DOL layout for form year 2024. Filing 20251015052638NAL0008291282001, received 2025-10-15.

Service providers paid directly by the plan

ProviderRelationshipService codesDirect compensationIndirect
MMA SECURITIES, LLCrecordkeeperINVESTMENT/FINANCIAL ADVI 15 Recordkeeping and information management; 21 Trustee (bank, trust company or similar); 49 Other services; 50 Direct payment from the plan; 64 Recordkeeping fees; 99 Other fees $160,611no
ADP, INC.recordkeeperRECORD KEEPER 37 Participant loan processing; 50 Direct payment from the plan; 15 Recordkeeping and information management; 64 Recordkeeping fees; 21 Trustee (bank, trust company or similar); 49 Other services; 99 Other fees; 26 Investment advisory (participants) $124,593yes
ADP BROKER-DEALERrecordkeeperRECORD KEEPER 60 Sub-transfer agency fees; 59 Shareholder servicing fees; 63 Distribution (12b-1) fees; 49 Other services; 99 Other fees $0yes

Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20251015052638NAL0008291282001, received 2025-10-15.

What changed since the 2023 plan year

Figure20232024Change
Total assets$77,496,149$92,054,19718.8%
Participants with a balance912881-3.4%
Administrative expenses$223,294$285,20527.7%
Recordkeeping fees per participant$103.40$125.7221.6%
Employer contributions$3,236,864$3,369,8994.1%

Prior filing 20241015160318NAL0058605042001, received 2024-10-15; the plan years are contiguous.

Alerts, claims and corrections

Alert me when this filing changes

One email when a new Form 5500 for Envision Pharma, Inc. 401(k) Plan appears in the Department of Labor data. Confirmation link first; unsubscribe link in every email.

Claim this plan

For the sponsor or its plan administrator: request to verify or annotate this page. A work email address at the sponsor speeds up verification.

Report a correction

Every figure is reproduced from the filing with its source. Tell us which figure and what the filing says instead.

Sponsor name as filed: ENVISION PHARMA, INC.; SEC registrant: Envision Pharma, Inc. (CIK 1556680, matched by EIN).